Private Equity in Healthcare: Shifting Focus to Patient Outcomes

In recent months, federal and state lawmakers have ramped up their scrutiny of private equity’s role in healthcare consolidation and pricing. The concern is that these investment firms may be prioritizing financial returns over patient outcomes, particularly through the acquisition and consolidation of physician practices and specialty platforms.

One industry insider, Matthew Bennett, a partner at Invidia Capital Management, believes this increased oversight is here to stay. “This scrutiny isn’t just a short-term political cycle; it’s an enduring feature that private equity firms will have to navigate,” he said. According to Bennett, the firms best positioned to succeed in the healthcare landscape are those that focus on improving health outcomes and lowering costs, rather than relying solely on consolidation-driven financial engineering.

The Decline of Physician Roll-Ups

Small practices play a vital role in healthcare delivery, but they face mounting administrative demands that can strain their resources. When private equity intermediates between patients and doctors, it often leads to negative consequences. “We don’t want to be sitting between a doctor and a patient telling a doctor what to do,” Bennett explained. This is where some private equity firms have run into trouble, particularly with large, multi-state physician businesses that rely on buying other practices in different states.

Many of these physician practice roll-ups have struggled due to over-expansion and integration challenges. “These deals often fail because the practices they buy are not successfully integrated,” Bennett noted. As a result, many PE funds operating these types of roll-ups have failed to demonstrate improvements in care quality or cost reduction.

The broader private equity investment community is pulling back from this strategy, and valuations in this segment of healthcare have dropped to historically low levels. Investors are becoming more selective, favoring firms that can prove they improve patient care rather than just generate financial returns. “The firms that succeed are those who use technology to eliminate inefficiencies and reduce waste,” Bennett said.

What Comes Next

As private equity firms adapt to this new landscape, the focus is shifting toward using technology to enhance healthcare delivery. This includes leveraging artificial intelligence (AI) and data analytics to streamline operations, improve patient outcomes, and lower costs. For example, AI can help identify patients at risk of developing chronic conditions earlier, allowing for more proactive and cost-effective interventions.

However, this shift also comes with its own set of challenges. Ensuring that technology is used ethically and does not exacerbate existing health disparities is crucial. Policymakers and industry leaders must work together to establish guidelines that protect patient privacy and ensure equitable access to care.

In the end, the success of private equity in healthcare will depend on their ability to align with the broader goals of improving public health. By prioritizing patient outcomes and using technology responsibly, these firms can play a positive role in shaping the future of healthcare.